Phenotypic variation in myocardial macrophage populations suggests a role for macrophage activation in SIV-associated cardiac disease

AIDS Research and Human Retroviruses

Volumn 23, Issue 4, 2007, Pages 515-524

  Yearley, Jennifer H ^a,b   Pearson, Christine ^b   Shannon, Richard P ^c   Mansfield, Keith G ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOPSY; CLUSTER ANALYSIS; CONTROLLED STUDY; DENDRITIC CELL; HEART DISEASE; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MACROPHAGE ACTIVATION; MONKEY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS MYOCARDITIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HEART DISEASES; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; MACROPHAGE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; MONOCYTES; MYOCARDITIS; PHENOTYPE; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 34247850851     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0211     Document Type: Article

References (43)

1. Joint United Nations Programme on HIV/AIDS: Report on the global AIDS epidemic: Executive summary. UNAIDS, Geneva, 2006.
2. Sani MU, Okeahialam BN, Aliyu SH, and Enoch DA: Human immunodeficiency virus (HIV) related heart disease: A review. Wien Klin Wochenschr 2005;117:73-81.
3. Langston C, Cooper ER, Goldfarb J, Easley KA, Husak S, Sunkle S, Starc TJ, and Colin AA: Human immunodeficiency virus-related mortality in infants and children: Data from the pediatric pulmonary and cardiovascular complications of vertically transmitted HIV (P(2)C(2)) Study. Pediatrics 2001;107:328-338.
4. Currie PF and Boon NA: Immunopathogenesis of HIV-related heart muscle disease: Current perspectives. AIDS 2003;17(Suppl. 1):S21-28.
5. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, and Torre D: Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 2000;40:282-284.
6. Steinman RM, Hawiger D, Liu K, Bonifaz L, Bonnyay D, Mahnke K, Iyoda T, Ravetch J, Dhodapkar M, Inaba K, and Nussenzweig M: Dendritic cell function in vivo during the steady state: A role in peripheral tolerance. Ann NY Acad Sci 2003;987:15-25.
7. Mosser DM: The many faces of macrophage activation. J Leukoc Biol 2003;73:209-212.
8. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.
9. Yearley JH, Pearson C, Carville A, Shannon RP, and Mansfield KG: SIV-associated myocarditis: Viral and cellular correlates of inflammation severity. AIDS Res Hum Retroviruses 2006;22:529-540.
10. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM, and Hahn BH: Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436-441.
11. Desrosiers RC: The simian immunodeficiency viruses. Annu Rev Immunol 1990;8:557-578.
12. Shannon RP, Simon MA, Mathier MA, Geng YJ, Mankad S, and Lackner AA: Dilated cardiomyopathy associated with simian AIDS in nonhuman primates. Circulation 2000;101:185-193.
13. Prabhu SD: Cytokine-induced modulation of cardiac function. Circ Res 2004;95:1140-1153.
14. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, and Giroir B: Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation 1998;97:1375-1381.
15. Woldbaek PR, Sande JB, Stromme TA, Lunde PK, Djurovic S, Lyberg T, Christensen G, and Tonnessen T: Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice. Am J Physiol 2005;289:H708-H714.
16. Chandrasekar B, Mummidi S, Claycomb WC, Mestril R, and Nemer M: Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. J Biol Chem 2005;280:4553-4567.
17. Fauci AS: Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-534.
18. Connolly NC, Riddler SA, and Rinaldo CR: Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approaches. AIDS Rev 2005;7:168-180.
19. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EG, and Schoen FJ: Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.
20. Horvath CJ, Hunt RD, Simon MA, Sehgal PK, and Ringler DJ: An immunohistologic study of granulomatous inflammation in SIV-infected rhesus monkeys. J Leukoc Biol 1993;53:532-540.
21. Hendricks EE, Lin KC, Boisvert K, Pauley D, and Mansfield KG: Alterations in expression of monocyte chemotactic protein-1 in the simian immunodeficiency virus model of disseminated Mycobacterium avium complex. J Infect Dis 2004;189:1714-1720.
22. Chesebro B, Wehrly K, Nishio J, and Perryman S: Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J Virol 1992;66:6547-6554.
23. Toohey K, Wehrly K, Nishio J, Perryman S, and Chesebro B: Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread Virology 1995;213:70-79.
24. Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, deBakker C, Alvarez X, and Lackner AA: Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: Implications for the neuropathogenesis of AIDS. J Exp Med 2001;193:905-915.
25. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, and Moestrup SK: Identification of the haemoglobin scavenger receptor. Nature 2001;409:198-201.
26. Moestrup SK and Moller HJ: CD163: A regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 2004;36:347-354.
27. Gown AM, Tsukada T, and Ross R: Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986;125:191-207.
28. Adams CW and Poston RN: Macrophage histology in paraffin-embedded multiple sclerosis plaques is demonstrated by the monoclonal pan-macrophage marker HAM-56: Correlation with chronicity of the lesion. Acta Neuropathol (Berl) 1990;80:208-211.
29. Scholler N, Hayden-Ledbetter M, Dahlin A, Hellstrom I, Hellstrom KE, and Ledbetter JA: Cutting edge: CD83 regulates the development of cellular immunity. J Immunol 2002;168:2599-2602.
30. Zhou LJ and Tedder TF: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 1996;93:2588-2592.
31. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, and Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
32. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, and Ottenhoff TH: Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol 2006;79:285-293.
33. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, Dereuddre-Bosquet N, Dormont D, and Gras G: Macrophage activation switching: An asset for the resolution of inflammation. Clin Exp Immunol 2005;142:481-489.
34. Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, and Landis RC: Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: Antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 2004;94:119-126.
35. Baeten D, Moller HJ, Delanghe J, Veys EM, Moestrup SK, and De Keyser F: Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Arthritis Rheum 2004;50:1611-1623.
36. Frings W, Dreier J, and Sorg C: Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect. FEBS Lett 2002;526:93-96.
37. Hogger P and Sorg C: Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. Biochem Biophys Res Commun 2001;288:841-843.
38. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, and Schmitz G: Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 2000;67:97-103.
39. Goerdt S and Orfanos CE: Other functions, other genes: Alternative activation of antigen-presenting cells. Immunity 1999;10:137-142.
40. Schebesch C, Kodelja V, Muller C, Hakij N, Bisson S, Orfanos CE, and Goerdt S: Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology 1997;92:478-486.
41. Porcheray F, Samah B, Leone C, Dereuddre-Bosquet N, and Gras G: Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a pro-inflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production. Virology 2006;349:112-120.
42. Kim WK, Alvarez X, Fisher J, Bronfin B, Westmoreland S, McLaurin J, and Williams K: CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am J Pathol 2006;168:822-834.
43. Choi YK, Whelton KM, Mlechick B, Murphey-Corb MA, and Reinhart TA: Productive infection of dendritic cells by simian immunodeficiency virus in macaque intestinal tissues. J Pathol 2003;201:616-628.